Open Access Open Access  Restricted Access Subscription or Fee Access

Efficacy of Jawarish Falafali in Siman Mufrit (obesity): A pre-post analytical clinical study.

Zeyaul Haque, Shazia Parveen Farooqui, Azhar Hasan Khan

Abstract


Background & Objectives:  Obesity (Siman Mufrit) is characterized by excess adipose tissue mass and increased BMI. Obesity has already reached epidemic proportions. In 2016, 1.9 billion adults worldwide were overweight. Of these over 650 million were obese. About 340 million adolescents (aged 5-19) and 41 million children (age < 5) were overweight or obese. NFHS-4 (2015-16) reported that obesity in India doubled in the last decade. Obesity is strongly associated with various cardiovascular,  metabolic, and systemic disorders. In Unani literature, Siman Mufrit is categorized as a balghami disease. Management includes dieto-therapy, pharmacotherapy and regimenal therapy. Treatment modalities should have har-yabis effect. Also, mudir, mushil, moarriq, musakhkhin, mulattif, muhallil and mufattit drugs are useful. Consequently, Jawarish Falafali, a Unani compound formulation was selected for study to substantiate its efficacy in Siman Mufrit (obesity) on scientific parameters.

Methods: The study-design was single-arm pre-and post-analysis clinical trial with 30 subjects aged between 18-60 years and having BMI between 30-40 kg/m2. The test drug Jawarish Falafali was given orally 5 gm OD for 60 days. Follow-up was done fortnightly. Efficacy was assessed by change in bodyweight, BMI, waist circumference, waist-hip ratio and lipid profile. The outcome was analyzed using appropriate statistical methods.

Results: A significant decrease (p<0.001) was observed in all primary outcome measures i.e. body weight, BMI, waist circumference, waist-hip ratio after treatment. Also, a significant reduction in lipid profile (TC, TG and LDL) except HDL (p=0.083) was detected.

Interpretation & Conclusion: This study revealed that the test drug effectively reduced obesity.


Keywords


Obesity; Siman Mufrit; Jawarish Falafali; Unani

Full Text:

PDF

References


Agarwal AK, Gupta P, Kamath SA, Nadkar MY, Singal RK et al. API Textbook of Medicine. 9th ed. Mumbai: Association of Physician of India. 2012; 2:1275- 79.

[Obesity and overweight [Internet]. WHO [cited 07 May 2020]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight

Hales CM, Carroll MD et al. Prevalence of Obesity Among Adults and Youth: United States, 2015–2016. NCHS Data Brief No. 288, October 2017. Retrieved on 10 Oct 2018 Available from: https://www.cdc.gov/nchs/data/databriefs/db288.pdf

Finkelstein EA, Trogdon JG et al. Annual Medical Spending Attributable to Obesity: Payer and Service-Specific Estimates Health Affairs. 2009; 28(5): 822-831. [doi:10.1377/hlthaff.28.5.w822]

Wang YC, McPherson K, Tim Marsh, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet. 2011; 378:815–25.

Marie Ng, Tom Fleming, Robinson M et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2014; 384(9945): 766–781. doi:10.1016/s0140-6736(14)60460-8

India’s obesity doubled in 10 years: NFHS-4 [Internet] [cited 22 Nov 2018] Available from: https://www.downtoearth.org.in/news/health/nfhs-4-highlights-india-has-become-obese-more-than-doubled-in-one-decade-only-52527.

Pradeepa R, Anjana RM, Joshi SR, Bhansali A et al. Prevalence of generalized & abdominal obesity in urban & rural India- the ICMR-INDIAB Study (Phase-I) [ICMR- NDIAB-3]. Indian J Med Res. 2015 Aug;142(2):139-50. [PMID:26354211]

Robert F. Kushner, Weight Loss Strategies for Treatment of Obesity: Lifestyle Management and Pharmacotherapy. Ypcad. 2018, doi:10.1016/j.pcad.2018.06.001

WHO: 10 facts on obesity. [Internet] [cited on 18 Nov 2019] Available from: https://www.who.int/features/factfiles/obesity/en/

Kinlen D, Cody D, O’Shea D. Complications of obesity. QJM: An International Journal of Medicine. 2018; 111(7):437–443.

Kopelman P. Health risks associated with overweight and obesity. Obesity Reviews. 2007; 8(s1):13–17. [doi:10.1111/j.1467-789x.2007.00311.x]

Harrison T, Jamson L, Fauci A, Kasper D. Harrison's principles of internal medicine. 20th ed. New York; McGraw-Hill; 2018:2837-2850

Burhanuddin Nafis. Kulliyat Nafisi. Translated by Hakim Kabiruddin. New Delhi, Idara Kitab shifa, 1954; 1: 268.

Ahmed HSI. Introduction to Al- Umur Al-Tabiah. New Delhi: CCRUM; 2009:108-110.

Alam A, Ahmad S, Husain S, Haider N. Unani Approach for Simn-E -Mufrit/ Farbahi (Obesity) Management: A Review. Asian Academic Research Journal of Multidisciplinary 2013; 1(12): 278-292.

Jalinoos. Kitab fil Mizaj: (Urdu Translation by Rahman HSZ). Aligarh: Ibn Sina Academy; 2008: 138-141.

Chandpuri K. Moojizal Qanoon. 3rd ed. Delhi: Qaumi Council Baraye Farogh Urdu Zaban; 1998; 99:459-60

Ibn Sina. Al Qanoon fit Tib. (Urdu translation by Kantoori GH). New Delhi: Idara Kitabush Shifa; 2010:93,179,1445-47.

Razi Abu Bakr MBZ. Kitab Al Hawi (Urdu Translation by CCRUM). New Delhi: CCRUM; 1999; 6:183,200-211,236,238-39.

Razi AMBZ. Kitabul Mansoori (Urdu translation). New Delhi: CCRUM; 1991:223.

Tabari AR. Firdausul Hikmat (Urdu translation by Sanbhali HMAS). Deoband: Faisal publications; 2002:112-113.

Arzani HA. Tibbe Akbar. Deoband: Faisal Publications; YNM:756, 758.

Anonymous: Qarabadeen Majeedi. New Delhi: Ajanta offset and publications; 1986: 56-57

Ghani N. Khazainul Adwiya. New Delhi: Idara Kitab ush Shifa; YNM: 206-08, 226, 468-70, 495-96, 509, 775, 869,1231-34.

Kazemipoor M, Radzi M, Hajifaraji M, Haerian BS et al. Antiobesity Effect of Caraway Extract on Overweight and Obese Women: A Randomize, Triple-Blind, Placebo-Controlled Clinical Trial. Evidence Based Complementary and Alternative Medicine. 2013:1-9. [doi:10.1155/2013/928582]

Pourahmadi M, Afshoon A, Jahromi HK. Effect of aqueous extract of caraway seeds on ghrelin hormone in male rats. Pharmacophore. 2017; 8(6s):1-5.

Lemhadri A, Hajji L et al. Cholesterol and triglycerides lowering activities of caraway fruits in normal and streptozotocin diabetic rats. Journal of Ethnopharmacology 2006; 106:321–326.

Saghir MR, Sadiq S, Nayak S, Tahir MU. Hypolipidemic effect of aqueous extract of Carum Carvi (black Zeera) seeds in diet induced hyperlipidemic rats. Pak J Pharm Sci. 2012; 25(2): 333-337. [PMID:22459457]

Haque MR, Ansari HS. Anti-Obesity Effect of Arq Zeera and Its Main Components Thymol and Cuminaldehyde in High Fat Diet Induced Obese Rats. Drug Res (2018) [https://doi.org/10.1055/a-0590-1956]

Shah SS, Shah GB, Singh SD, Gohil PV, Chauhan K, Shah KA, et al. Effect of piperine in the regulation of obesity-induced dyslipidemia in high-fat diet rats. Indian J Pharmacol. 2011; 43:296-9.

Lee SW, Rho M-C, Park HR, Choi J-H, Kang JY, Lee JW et al. Inhibition of Diacylglycerol Acyltransferase by Alkamides Isolated from the Fruits of Piper Longum and Piper nigrum. Journal of Agricultural and Food Chemistry. 2006; 54(26): 9759–9763. doi:10.1021/jf061402e

Meriga B, Parim B, Chunduri VR et al. Antiobesity potential of Piperonal: promising modulation of body composition, lipid profiles and obesogenic marker expression in HFD-induced obese rats. Nutrition & Metabolism. 2017; 14:72.

Goyal RK, Kadnur SV. Beneficial effects of Zingiber officinale on goldthioglucose induced obesity. Fitoterapia. 2006; 77:160–163.

Attari VE, Ostadrahimi A, Jafarabadi MA et al. Changes of serum adipocytokines and body weight following Zingiber officinale supplementation in obese women: A RCT. European Journal of Nutrition. 2015; 55(6):2129–2136.

Ismail NS. Protective effects of aqueous extracts of cinnamon and ginger herbs against obesity and diabetes in obese diabetic rat. World Journal of Dairy & Food Sciences. 2014; 9(2):145–153.

ElRokh EM, Yassin NAZ et al. Antihypercholesterolaemic effect of ginger rhizome (Zingiber officinale) in rats. Inflammopharmacol. 2010; 18:309–315.

Sharma I, Gusain D, Dixit VP. Hypolipidaemic and antiatherosclerotic effects of Zingiber offlcinale in Cholesterol Fed Rabbits. Phytotherapy Research. 1996; 10:517-18.

Khan M, Safdar M, Khattak KN, Anderson RA. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. 2003; 26(12):3215-18.

Jain SG, Puri S, Misra A et al. Effect of oral cinnamon intervention on metabolic profile and body composition of Asian Indians with metabolic syndrome: a randomized double -blind control trial; Lipids in Health and Disease. 2017; 16:113.

Iyer D, Patil UK. Assessment of Antihyperlipidemic and Antitumor Effect of Isolated Active Phytoconstituents from Apium graveolens L. through Bioassay-Guided Procedures, Journal of Dietary Supplements. 2018. doi:10.1080/19390211.2018.1448921

Cheng MC, Ker YB, Yu HT et al. Chemical Synthesis of 9(Z)-Octadecenamide and Its Hypolipidemic Effect: A Bioactive Agent Found in the Essential Oil of Mountain Celery Seeds; J. Agric. Food Chem. 2010; 58: 1502-1508 [DOI:10.1021/jf903573g]

Sina I, Kulliyat Qanoon (translated by Hakim Kabiruddin). New Delhi: Ejaz Publishing House; 2006: 222.




DOI: https://doi.org/10.37591/joayush.v9i3.2182

Refbacks

  • There are currently no refbacks.